We determined the feasibility of human papillomavirus (HPV) detection in cervical exfoliated cells collected as dry swab samples. Both dry cervical swab and specimen transport medium (STM) cervical swab samples were collected from 135 patients attending either colposcopy or women's clinics in Guayaquil, Ecuador, who had a cytology diagnosis within 6 months. HPV was detected by dot blot hybridization and genotyped by the liquid bead microarray assay (LBMA). Overall, 23.1% of dry samples were positive for any high-risk HPV types, and 24.6% of STM samples were positive for any high-risk HPV types. Of 125 paired samples, the type-specific high-risk HPV proportion positive agreement was 60.7% (kappa, 0.69; 95% confidence interval [CI], 0.53 to 0.82). Of six women with cytological evidence of invasive cervical cancer, high-risk HPV DNA was detected in three of their STM samples and in five of their dry samples. Dry samples were more likely to be insufficient for HPV testing than STM samples. Consistent with this observation, the amount of genomic DNA quantitated with the -actin gene was almost 20 times lower in dry samples than in STM samples when detected by the real-time TaqMan assay; however, HPV DNA viral loads in dry samples were only 1.6 times lower than those in matched STM samples. We concluded that exfoliated cervical cells could be collected as dry swab samples for HPV detection.Human papillomavirus (HPV) infection causes warts and various cancerous and precancerous lesions in men and women. It has been established that high-risk HPV infection is the etiological agent of cervical cancer, which affects almost half a million women worldwide and has a 50% mortality rate (12,18). In developed countries, cervical cancer control relies on routine cytology screening to detect and treat cervical cancer precursor lesions, and HPV detection has been used for the management of women with equivocal cytology results (1,4,14). In resource-poor settings where cytology-based screening is difficult to implement, HPV detection has been proposed as the alternative primary screening test for cervical cancer (4, 17).Currently, HPV detection is performed on cervical samples collected in liquid medium by a trained clinician, which is often impractical or unavailable in remote areas and developing countries. Several approaches have been proposed to simplify the sample collection process for HPV detection. For example, HPV detection in self-collected vaginal swab samples has been proposed as a method that would eliminate the need for clinical visits, and we have shown that HPV detected in selfcollected vaginal swab samples stored in specimen transport medium (STM) had sensitivity and specificity similar to those of clinician-collected cervical swab samples stored in STM for detecting cervical neoplasia (16). Currently, cervical exfoliated cells are collected either in phosphate-buffered saline (PBS), which is inexpensive but requires constant refrigeration, or in various liquid media, such as STM or Preservcyt, which preserve HPV D...